Showing results (81-90 of 718) with videos related to

Sort By:
Pageof 72
Respiratory Research|January 28, 2023
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?Ekaterina Safonova, Barbara P Yawn, Tobias Welte, et al.
European Journal of Pharmacology|January 26, 2006
Nanomedicine for respiratory diseasesUlrich Pison, Tobias Welte, Michael Giersig, et al.
Respiratory Medicine|February 21, 2016
Current thinking and new paradigm for COPDTobias Welte, Kenneth R Chapman, Helgo Magnussen, et al.
Deutsches Arzteblatt International|July 26, 2013
Fluid replacement with hydroxyethyl starch in critical care--a reassessmentChristiane S Hartog, Tobias Welte, Peter Schlattmann, et al.
International Journal of Antimicrobial Agents|August 13, 2019
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adultsTobias Welte, Michal Kantecki, Gregory G Stone, et al.
Deutsches Arzteblatt International|February 16, 2023
The Diagnosis and Treatment of COPD and Its ComorbiditiesKathrin Kahnert, Rudolf A Jörres, Jürgen Behr, et al.
Intensive Care Medicine|June 22, 2006
Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: Meta-analysis of randomized controlled trialsRalf-Peter Vonberg, Tim Eckmanns, Tobias Welte, et al.
Micron (Oxford, England : 1993)|November 28, 2006
Ultrastructural types of alveolar macrophages in bronchoalveolar lavages from patients with pulmonary sarcoidosisOlaf Burkhardt, Hartmut Lode, Tobias Welte, et al.
Deutsches Arzteblatt International|May 25, 2016
The Pharmacological Treatment of Chronic Obstructive Pulmonary DiseaseAdrian Gillissen, Peter Haidl, Martin Khlhäufl, et al.
Pneumologie (Stuttgart, Germany)|July 7, 2026
Outcomes and risk factors for mortality in patients with pulmonary non-tuberculous mycobacterial infections: A single-center retrospective cohort studyZsolt Gurabi, Markus Zenner, Wilhelmina van den Dool, et al.
Pageof 72